← Leaderboards
Jonathan Peter
University Of Cape Town Lung Institute
$647,957
Attributed
$647,957
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $194.4K · FY2018–22$200K$150K$100K$50K$0
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$647,957 · 1
By mechanism
K43$647,957 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Cessation Of Life”
- Xinhua Li · Nano Terra, Inc.$32,520,955
- Christopher Barnaby Nelson · University Of Melbourne$27,954,628
- Abraham Aizer Brody · New York University School Of Medicine$21,799,826
- Peter W Pisters · University Of Tx Md Anderson Can Ctr$20,810,724
- Jeffrey Reich · Sparian Biosciences, Inc.$20,633,040
- Beth Baseler · Leidos Biomedical Research, Inc.$18,109,529
Research focus
Cessation Of LifeAcuteAcquired Immunodeficiency SyndromeAbacavirAffectAfricaAfricanAfrica South Of The SaharaAdverse ReactionsAllelesAntigensAntiretroviral TherapyAntitubercular AgentsAreaBiologyBiopsy SpecimenBurden Of IllnessCarbamazepineCd3 AntigensCd4 Positive T LymphocytesCd8b1 GeneCd8-Positive T-LymphocytesCellsClinical Phenotype
Grant awards (6)
IMmune-mediated Adverse drug Reactions In African HIV endemic setting (IMARI-SA study)$113,400
K43 · FY2022 · TW · contact PI
IMmune-mediated Adverse drug Reactions In African HIV endemic setting (IMARI-SA study)$113,400
K43 · FY2021 · TW · contact PI
IMmune-mediated Adverse drug Reactions In African HIV endemic setting (IMARI-SA study)$80,957
K43 · FY2021 · TW · contact PI
IMmune-mediated Adverse drug Reactions In African HIV endemic setting (IMARI-SA study)$113,400
K43 · FY2020 · TW · contact PI
IMmune-mediated Adverse drug Reactions In African HIV endemic setting (IMARI-SA study)$113,400
K43 · FY2019 · TW · contact PI
IMmune-mediated Adverse drug Reactions In African HIV endemic setting (IMARI-SA study)$113,400
K43 · FY2018 · TW · contact PI